Cargando…
Generation of an Oncolytic Herpes Simplex Viral Vector Completely Retargeted to the GDNF Receptor GFRα1 for Specific Infection of Breast Cancer Cells
Oncolytic herpes simplex viruses (oHSV) are under development for the treatment of a variety of human cancers, including breast cancer, a leading cause of cancer mortality among women worldwide. Here we report the design of a fully retargeted oHSV for preferential infection of breast cancer cells th...
Autores principales: | Hall, Bonnie L., Leronni, Daniela, Miyagawa, Yoshitaka, Goins, William F., Glorioso, Joseph C., Cohen, Justus B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700293/ https://www.ncbi.nlm.nih.gov/pubmed/33233403 http://dx.doi.org/10.3390/ijms21228815 |
Ejemplares similares
-
Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System
por: Artusi, Sara, et al.
Publicado: (2018) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
Novel mutations in U(L)24 and gH rescue efficient infection of an HSV vector retargeted to TrkA
por: Marzulli, Marco, et al.
Publicado: (2023) -
Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors
por: Kuroda, Seiji, et al.
Publicado: (2022) -
A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells
por: Leoni, Valerio, et al.
Publicado: (2017)